Healthcare start-up Zorgers raises angel round
The Home Healthcare market is expected to be US $ 14.2 by 2025
The Home Healthcare market is expected to be US $ 14.2 by 2025
The capsules are the generic version of the reference listed drug Mycobutin
The company will collaborate with U.S.-based colleagues to help life sciences companies improve commercial effectiveness
Doctors can now analyse their historical prescriptions within a few clicks enabling them to identify different cohorts of patients and the treatment given to them
It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home
Both companies will combine their expertise to channel real-world evidence toward ground-breaking new treatments in rare diseases
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Flipkart also announced its foray into the healthcare sector through the launch of Flipkart Health+
Subscribe To Our Newsletter & Stay Updated